Page 33 - <>期刊 v2

33
Back ID D N U | iddnu@suntrap.com | www.suntrap.com

Kuhlmann C, Mayer CM, Claassen M, et al. Breakthrough Infec- Pfizer and BioNTech Provide Update on Omicron Variant (commu-
tions with SARS-CoV-2 Omicron Variant Despite Booster Dose niqué de presse Pfizer, 8 décembre 2021)
of mRNA Vaccine. SSRN. [Preprint]. Posted: 10 Dec 2021. doi:
0.2139/ssrn.3981711 LIRE aussi : Variant Omicron : un risque d’échappement immuni-
taire
Wilhelm A, Widera M, Grikscheit K, et al. Reduced Neutraliza-
tion of SARS-CoV-2 Omicron Variant by Vaccine Sera and Mono- Covid-19 : ce qu’on sait et ce qu’on ignore sur le nouveau variant
clonal Antibodies. medRxiv. Posted December 11, 2021. doi: Omicron (B.1.1.529)
10.1101/2021.12.07.21267432
13 DÉCEMBRE 2021 PAR MARC GOZLAN LE MONDE
Sheward DJ, Kim C, Pankow A. Quantification of the neutralization
resistance of the Omicron Variant of Concern. [Preprint].

Cele S, Jackson L, Khan K, et al. SARS-CoV-2 Omicron has exten-
sive but incomplete escape of Pfizer BNT162b2 elicited neutraliza-
tion and requires ACE2 for infection. medRxiv. Posted December
09, 2021. doi: 10.1101/2021.12.08.21267417.

Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19
vaccines against the Omicron (B.1.1.529) variant of concern. [Pre-
print]. Posted 9 Dec 2021.

Cao Y, Wang J, Fanchong Jian F, et al. B.1.1.529 escapes the majority
of SARS-CoV-2 neutralizing antibodies of diverse epitopes. bioRx-
iv. Posted December 9, 2021. doi: 10.1101/2021.12.07.470392

Sur le web :

UK coronavirus (COVID-19) alert level increased from Level 3 to
Level 4. Department of Health and Social Care. Published 12 De-
cember 2021)

Evidence paper on rapid rise of Omicron cases. Scottish Govern-
ment. Published: 10 Dec 2021

Epidemiological update: Omicron variant of concern (VOC) – data
as of 10 December 2021 (12:00). ECDC. 10 Dec 2021.

Status of the SARS-CoV-2 variant Omicron in Denmark. Staten Se-
rum Institut (10 Dec 2021) 文章来源：
Le Monde le 13-12-2021 par MARC GOZLAN